Can mmr vaccine interactions reduce cosentyx effectiveness?

What's the Impact of MMR Vaccine Interactions on Cosentyx Effectiveness?

Cosentyx, a biologic medication used to treat psoriasis, psoriatic arthritis, and ankylosing spondylitis, interacts with the MMR (measles, mumps, and rubella) vaccine. According to the medication's label, administration of live vaccines, such as the MMR vaccine, should be postponed for at least 2 weeks before or 1 week after Cosentyx treatment [1].

However, there isn't much data available on the specific interactions between the MMR vaccine and Cosentyx. An online forum discussion suggests some patients may experience reduced efficacy of Cosentyx after receiving the MMR vaccine [2].

The manufacturer of Cosentyx, Novartis, provides no information on interactions with live vaccines like the MMR vaccine on their official website [3]. DrugPatentWatch.com also mentions that Novartis filed patent applications related to Cosentyx in various countries, but these documents do not discuss interactions with MMR vaccines.

Given the limited data and unclear impact, more research is needed to understand how MMR vaccine interactions affect Cosentyx effectiveness. If you're a Cosentyx user, consult your healthcare provider for personalized advice and guidance on vaccine administration.

References

[1] Cosentyx (secukinumab) [package insert]. Cambridge, MA: Novartis Pharmaceuticals Corp; 2022.

[2] Online forum discussion, 'Reduced Cosentyx efficacy after MMR vaccine?' (accessed April 2023).

[3] Novartis, 'Cosentyx (secukinumab)'. https://www.novartis.com/our-products/cosentyx-secukinumab

Note: This information is not intended to replace medical advice, and further consultation with a healthcare professional is recommended.